Galapagos NV
GLPG
#4563
Rank
$2.11 B
Marketcap
$31.59
Share price
-0.57%
Change (1 day)
17.22%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -$0.54 Billion USD

According to Galapagos NV's latest financial reports the company's current earnings are $0.32 Billion USD. In 2024 the company made an earning of -$5.78 Million USD, an increase over its 2023 earnings that were of -$33.55 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.54 Billion9113.23%
2024 -$5.78 Million-82.77%
2023 -$33.55 Million-85.59%
2022 -$0.24 Billion60.71%
2021 -$0.15 Billion-60.08%
2020 -$0.37 Billion-331.44%
2019 $0.15 B-523.76%
2018 -$37.01 Million-72.34%
2017 -$0.14 Billion-329.59%
2016 $58.27 M-144.3%
2015 -$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
$13.09 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
$32.39 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$9.10 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
$1.66 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-$88.95 Million-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$8.13 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.77 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$9.32 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$23.09 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA